# BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
> **ANDA076560** · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2004-06-10
## Drug
- **FDA Application Number:** ANDA076560
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
- **Generic name:** BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE
- **Active ingredients:** ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LGM PHARMA
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2004-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076560)
---
*AI Analytics · CC0 1.0*